Toll-like receptor 4 participates in gastric mucosal protection through Cox-2 and PGE2

Yan Zhang1, Huan Chen, Li Yang

  • 1Division of Gastroenterology, West China Hospital of Sichuan University, GuoXue Street 37, Chengdu 610041, Sichuan, China. fengyixx@sohu.com

Abstract

Insights

Toll-like receptor 4 (TLR4) signaling activates in the stomach after ethanol injury. This pathway protects the gastric lining by increasing cyclooxygenase-2 (Cox-2) and prostaglandin E2 (PGE2) production.

Area of Science:

  • Gastroenterology
  • Immunology
  • Cell Biology

Background:

  • Ethanol-induced gastric injury is a significant clinical concern.
  • Toll-like receptors (TLRs) play crucial roles in innate immunity and inflammation.
  • The specific role of TLRs in gastric cytoprotection remains incompletely understood.

Purpose of the Study:

  • To investigate the involvement of Toll-like receptors (TLRs) in protecting the gastric mucosa from ethanol-induced damage.
  • To elucidate the molecular mechanisms underlying TLR-mediated gastric cytoprotection.

Main Methods:

  • Utilized C57BL/6J, C3H/HeOuJ, and C3H/HeJ mouse models of ethanol-induced gastric injury.
  • Assessed the expression of TLR4, cyclooxygenase-2 (Cox-2), and prostaglandin E2 (PGE2) using immunohistochemistry, Western blotting, and ELISA.
  • Quantified macrophage infiltration and MIP-2 expression.

Main Results:

  • TLR4 expression was upregulated in the gastric mucosa of C57BL/6J mice 4 hours post-ethanol administration.
  • Gastric injury was more severe in C3H/HeJ mice compared to C3H/HeOuJ mice.
  • Upregulation of Cox-2 and PGE2, along with increased macrophage infiltration and MIP-2 expression, was observed exclusively in C3H/HeOuJ mice.

Conclusions:

  • TLR4 signaling is activated in the mouse stomach following ethanol injury.
  • The cytoprotective effects of TLR4 are mediated by the induction of Cox-2 expression and subsequent PGE2 production.
  • These findings highlight TLR4 as a potential therapeutic target for managing alcohol-induced gastric damage.

Related Concept Videos

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining. Bicarbonate,...